Edwards Lifesciences CorporationEWNYSE
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+4.1%
5Y CAGR+6.7%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+4.1%/yr
vs +9.7%/yr prior
5Y CAGR
+6.7%/yr
Consistent
Acceleration
-5.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.07B | +11.5% |
| 2024 | $5.44B | +8.6% |
| 2023 | $5.01B | -6.9% |
| 2022 | $5.38B | +2.9% |
| 2021 | $5.23B | +19.3% |
| 2020 | $4.39B | +0.9% |
| 2019 | $4.35B | +16.8% |
| 2018 | $3.72B | +8.4% |
| 2017 | $3.44B | +15.9% |
| 2016 | $2.96B | - |